Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Accumulated Expenses: 2022-2024

Historic Accumulated Expenses for Legend Biotech (LEGN) over the last 3 years, with Dec 2024 value amounting to $16.3 million.

  • Legend Biotech's Accumulated Expenses fell 72.73% to $24.1 million in Q1 2025 from the same period last year, while for Mar 2025 it was $24.1 million, marking a year-over-year decrease of 72.73%. This contributed to the annual value of $16.3 million for FY2024, which is 77.12% down from last year.
  • Legend Biotech's Accumulated Expenses amounted to $16.3 million in FY2024, which was down 77.12% from $71.5 million recorded in FY2023.
  • In the past 5 years, Legend Biotech's Accumulated Expenses registered a high of $127.4 million during FY2022, and its lowest value of $16.3 million during FY2024.
  • Over the past 3 years, Legend Biotech's median Accumulated Expenses value was $71.5 million (recorded in 2023), while the average stood at $71.7 million.
  • Data for Legend Biotech's Accumulated Expenses shows a maximum YoY crashed of 77.12% (in 2024) over the last 5 years.
  • Legend Biotech's Accumulated Expenses (Yearly) stood at $127.4 million in 2022, then crashed by 43.90% to $71.5 million in 2023, then slumped by 77.12% to $16.3 million in 2024.